---
figid: PMC4571192__nihms643960f4
figlink: /pmc/articles/PMC4571192/figure/F4/
number: F4
caption: 'Arachidonic acid metabolites are critical mediators of host defense against
  Mtb. Candidate HDTs that affect this metabolic pathway are shown in shaded boxes
  at their site of action on the pathway. (A). In controlled TB disease, the arachidonic
  acid pathway yields balanced levels of TNF and Type I IFNs, which control infection.
  (B). In uncontrolled TB disease with elevated levels of LTA4, TNF, and Type I IFNs,
  eicosanoid signaling is out of balance and favors production of LTA4 at the expense
  of PGE2. (C). Restoration of equilibrium and control of disease may be achieved
  with zileuton, which block 5-LO. As a consequence LTA4 levels are reduced and, indirectly,
  PGE2 levels become elevated, which reduces Type I IFNs and TNF, and permits control
  of the bacteria. Other drugs such as aspirin or valdecoxib, which inhibit PGE2 production,
  may be useful when the eicosanoid pathway imbalance favors production of PGE2 at
  the expense of LTA4. Abbreviations: COX, cyclooxygenase; PGE2, prostaglandin E2;
  15LO, 15-lipoxygenase; 5LO, 5-lipoxygenase; LXA4, lipoxin A4; LTA4, leukotriene
  A4.'
pmcid: PMC4571192
papertitle: 'New tricks for old dogs: countering antibiotic resistance in tuberculosis
  with host-directed therapeutics.'
reftext: Thomas R. Hawn, et al. Immunol Rev. ;264(1):344-362.
pmc_ranked_result_index: '2640'
pathway_score: 0.9438578
filename: nihms643960f4.jpg
figtitle: 'New tricks for old dogs: countering antibiotic resistance in tuberculosis
  with host-directed therapeutics'
year: ''
organisms:
- Homo sapiens
ndex: 4a24e510-deb5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4571192__nihms643960f4.html
  '@type': Dataset
  description: 'Arachidonic acid metabolites are critical mediators of host defense
    against Mtb. Candidate HDTs that affect this metabolic pathway are shown in shaded
    boxes at their site of action on the pathway. (A). In controlled TB disease, the
    arachidonic acid pathway yields balanced levels of TNF and Type I IFNs, which
    control infection. (B). In uncontrolled TB disease with elevated levels of LTA4,
    TNF, and Type I IFNs, eicosanoid signaling is out of balance and favors production
    of LTA4 at the expense of PGE2. (C). Restoration of equilibrium and control of
    disease may be achieved with zileuton, which block 5-LO. As a consequence LTA4
    levels are reduced and, indirectly, PGE2 levels become elevated, which reduces
    Type I IFNs and TNF, and permits control of the bacteria. Other drugs such as
    aspirin or valdecoxib, which inhibit PGE2 production, may be useful when the eicosanoid
    pathway imbalance favors production of PGE2 at the expense of LTA4. Abbreviations:
    COX, cyclooxygenase; PGE2, prostaglandin E2; 15LO, 15-lipoxygenase; 5LO, 5-lipoxygenase;
    LXA4, lipoxin A4; LTA4, leukotriene A4.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - COX7A1
  - COX6B1
  - IFNA16
  - COX5A
  - IFNA14
  - IL1A
  - IFNA17
  - IFNA21
  - IFNB1
  - COX17
  - IL1B
  - COX4I2
  - IFNA13
  - COX6A1
  - COX6A2
  - IFNA1
  - IFNA7
  - COX7A2
  - COX7B
  - COX8A
  - LTA
  - NCAPG2
  - COX15
  - COX6B2
  - COX4I1
  - IFNA10
  - COX5B
  - IFNA2
  - IFNA4
  - COX10
  - IFNA5
  - COX7B2
  - COX8C
  - COX11
  - TNF
  - IFNA8
  - IFNA6
  - Valdecoxib
  - Aspirin
  - Ibuprofen
  - PGE
  - PGE2
genes:
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A1
  entrez: '1346'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B1
  entrez: '1340'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA16
  entrez: '3449'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5A
  entrez: '9377'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA14
  entrez: '3448'
- word: IL-1a/B
  symbol: IL-1A
  source: hgnc_alias_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA17
  entrez: '3451'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA21
  entrez: '3452'
- word: IFNa/B
  symbol: IFNB
  source: bioentities_symbol
  hgnc_symbol: IFNB1
  entrez: '3456'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX17
  entrez: '10063'
- word: IL-1a/B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I2
  entrez: '84701'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA13
  entrez: '3447'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A1
  entrez: '1337'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A2
  entrez: '1339'
- word: IFN
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA7
  entrez: '3444'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A2
  entrez: '1347'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B
  entrez: '1349'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8A
  entrez: '1351'
- word: LTA
  symbol: LTA
  source: hgnc_symbol
  hgnc_symbol: LTA
  entrez: '4049'
- word: Mtb
  symbol: MTB
  source: hgnc_alias_symbol
  hgnc_symbol: NCAPG2
  entrez: '54892'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX15
  entrez: '1355'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B2
  entrez: '125965'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA10
  entrez: '3446'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5B
  entrez: '1329'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA2
  entrez: '3440'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA4
  entrez: '3441'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX10
  entrez: '1352'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA5
  entrez: '3442'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B2
  entrez: '170712'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8C
  entrez: '341947'
- word: Cox
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX11
  entrez: '1353'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA8
  entrez: '3445'
- word: IFNa/B
  symbol: IFNA
  source: bioentities_symbol
  hgnc_symbol: IFNA6
  entrez: '3443'
chemicals:
- word: Valdecoxib
  source: MESH
  identifier: C406224
- word: Aspirin
  source: MESH
  identifier: D001241
- word: Ibuprofen
  source: MESH
  identifier: D007052
- word: PGE
  source: MESH
  identifier: D011458
- word: PGE2
  source: MESH
  identifier: D015232
diseases: []
figid_alias: PMC4571192__F4
redirect_from: /figures/PMC4571192__F4
figtype: Figure
---
